AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Global markets rose late Sunday as the U.S. and Iran signaled a pause in hostilities and agreed to talks, easing fear...
A family estate dispute escalates after a stepmother allegedly withholds $500,000 from a father's will, prompting leg...
Retirees increasingly face a stark geography choice: Original Medicare travels with you, while Advantage plans stay b...
Paramount’s move to revive G.I. Joe with a controversial hire is more than a movie decision—it’s a case study in risk...
Analysts say a terse, unhedged line buried in the FED minutes may be the strongest signal yet on future policy. Here’...
Markets swing as geopolitical tensions flare between the U.S. and Iran. This analysis traces the past CIA plan and ex...
As the 2027 COLA comes into view, rising Medicare premiums threaten to erode any gains for many seniors. Here's what ...
A quartet of high-yield ETFs are now producing double-digit income in 2026, each using a different approach. Here's a...
VOO remains the default way to own the market, but cheaper S&P 500 ETFs challenge the long-held view. The difference ...
As week three of the U.S.-Iran conflict begins, Democrats press for hearings while Republicans stay silent, sparking ...
A sudden political pivot put South Carolina in the spotlight as former President Trump floated Darline Graham Nordone...